WSJ.com: US Business
FDA Authorizes Pfizer-BioNTech Booster for 12- to 15-Year-Olds – U.S. health regulators cleared use of a Covid-19 booster from Pfizer and BioNTech in adolescents 12 to 15 years old, expanding access to an extra dose that could bolster the fight against the Omicron variant. …
